76 related articles for article (PubMed ID: 7526818)
1. Advanced prostate cancer with normal serum prostate-specific antigen values.
Cohen RJ; Haffejee Z; Steele GS; Nayler SJ
Arch Pathol Lab Med; 1994 Nov; 118(11):1123-6. PubMed ID: 7526818
[TBL] [Abstract][Full Text] [Related]
2. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
Wang W; Epstein JI
Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
[TBL] [Abstract][Full Text] [Related]
3. [Advanced prostate cancer with normal serum prostate-specific antigen values].
Komura T; Yamagiwa K; Ogura H; Kohjimoto Y; Ohkawa T; Inagaki T; Ebisuno S; Senzaki A
Hinyokika Kiyo; 1998 May; 44(5):303-6. PubMed ID: 9656099
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical study of neuroendocrine cells and prostate-specific antigen in prostate carcinoma].
Yao GY; Lai MD; Chen PH
Zhonghua Yi Xue Za Zhi; 1994 Mar; 74(3):161-2, 191-2. PubMed ID: 7522941
[TBL] [Abstract][Full Text] [Related]
5. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer.
Parwani AV; Marlow C; Demarzo AM; Mikolajczyk SD; Rittenhouse HG; Veltri RW; Chan TY
Am J Surg Pathol; 2006 Oct; 30(10):1231-6. PubMed ID: 17001152
[TBL] [Abstract][Full Text] [Related]
7. Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review.
Yashi M; Terauchi F; Nukui A; Ochi M; Yuzawa M; Hara Y; Morita T
Urol Oncol; 2006; 24(4):313-7. PubMed ID: 16818183
[TBL] [Abstract][Full Text] [Related]
8. [Changes in prostate-specific antigen in casodex (bicalutamide) monotherapy in a dose 150 mg/day given to patients with locally advanced and/or advanced prostatic cancer].
Kariakin OB; Sviridova TV; Tsodikova LB; Grishin GN; Sergeeva TN; Perekhrest MA; Donichkina EA
Urologiia; 2001; (4):26-9. PubMed ID: 11569230
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.
Moussa M; Kloth D; Peers G; Cherian MG; Frei JV; Chin JL
Clin Invest Med; 1997 Dec; 20(6):371-80. PubMed ID: 9413634
[TBL] [Abstract][Full Text] [Related]
10. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
[TBL] [Abstract][Full Text] [Related]
11. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
12. [Papillary adenocarcinoma of the prostate: report of 4 cases].
Miki J; Ikemoto I; Shimomura T; Kiyota H; Oisi Y; Kondo I; Madarame J; Endo K; Takahashi H
Hinyokika Kiyo; 2003 Jan; 49(1):21-4. PubMed ID: 12629776
[TBL] [Abstract][Full Text] [Related]
13. [Pathological features of prostate cancer in Chinese cohort detected through mass screening and their relationships with serum prostate specific antigen].
Gao HW; Li YL; Wu S; Wang YS; Pan YZ; Zhang L; Zhao XJ
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1300-2. PubMed ID: 12930681
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of the prostate-specific antigen in prostatic cancer].
Karseladze AI; Rytin IIe; Budunova IV
Arkh Patol; 2004; 66(2):3-7. PubMed ID: 15154373
[TBL] [Abstract][Full Text] [Related]
15. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
Tavora F; Epstein JI
Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
[TBL] [Abstract][Full Text] [Related]
16. Correlation of serum prostate specific antigen and quantitative immunohistochemistry.
Weir EG; Partin AW; Epstein JI
J Urol; 2000 Jun; 163(6):1739-42. PubMed ID: 10799172
[TBL] [Abstract][Full Text] [Related]
17. Serum calcitonin in small cell carcinoma of the prostate.
Sim SJ; Glassman AB; Ro JY; Lee JJ; Logothetis CJ; Liu FJ
Ann Clin Lab Sci; 1996; 26(6):487-95. PubMed ID: 8908318
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
19. Use of age-specific normal ranges for serum prostate-specific antigen.
Slovacek KJ; Riggs MW; Spiekerman AM; Speights VO
Arch Pathol Lab Med; 1998 Apr; 122(4):330-2. PubMed ID: 9648900
[TBL] [Abstract][Full Text] [Related]
20. [Various immunohistochemical markers of precancer and variants of prostate cancer].
Romanenko AM; Vorob'eva LR
Arkh Patol; 1995; 57(4):38-41. PubMed ID: 8526754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
